Qilu Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?
QILU has twenty-six approved drugs.
There is one tentative approval on QILU drugs.
Drugs and US Patents for Qilu
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Qilu | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 217265-002 | Feb 22, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Qilu | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 217265-004 | Feb 22, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Qilu Pharm Hainan | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 215316-001 | Aug 24, 2021 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Qilu | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 209218-001 | Oct 17, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Qilu Pharm Hainan | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 205648-001 | Sep 19, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Qilu | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 210552-001 | Jan 10, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.